These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10440070)

  • 1. An evaluation of susceptibility testing methods for ampicillin-sulbactam using a panel of beta-lactamase-producing bacteria.
    Siu LK; Lo JY; Cheng WL; Ho PL; Ng WS; Chau PY
    APMIS; 1999 Jul; 107(7):703-8. PubMed ID: 10440070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of beta-lactamase-producing Enterobacteriaceae.
    Siu LK; Cheng WL; Ho PL; Ng WS; Chau PY; Lo JY
    APMIS; 1998 Sep; 106(9):917-20. PubMed ID: 9808419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperacillin tazobactam compared with co-amoxiclav, ampicillin plus sulbactam and timentin against beta-lactamase-producing clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
    Traub WH; Leonhard B
    Chemotherapy; 1995; 41(5):345-52. PubMed ID: 8521736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.
    Oliver A; Pérez-Vázquez M; Martínez-Ferrer M; Baquero F; De Rafael L; Cantón R
    Antimicrob Agents Chemother; 1999 Apr; 43(4):862-7. PubMed ID: 10103192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S; Marre R
    Infection; 1991; 19(2):106-9. PubMed ID: 1646771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of TEM-1 β-Lactamase in the Predominance of Ampicillin-Sulbactam-Nonsusceptible
    Noguchi T; Matsumura Y; Kanahashi T; Tanaka M; Tsuchido Y; Matsumura T; Nakano S; Yamamoto M; Nagao M; Ichiyama S
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam.
    Bradford PA; Sanders CC
    Antimicrob Agents Chemother; 1993 Feb; 37(2):251-9. PubMed ID: 8452355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.
    Varaldo PE; Ripa S; Nicoletti G; Covelli I; Satta G; Carlone N; Fontana R
    Chemotherapy; 1990; 36(2):141-6. PubMed ID: 2178890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
    Villar HE; Jugo MB; Fernández-Lausi A; Farinati AE
    Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.
    Waltner-Toews RI; Paterson DL; Qureshi ZA; Sidjabat HE; Adams-Haduch JM; Shutt KA; Jones M; Tian GB; Pasculle AW; Doi Y
    Antimicrob Agents Chemother; 2011 Feb; 55(2):495-501. PubMed ID: 21135189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC.
    Firsov AA; Saverino D; Ruble M; Gilbert D; Manzano B; Medeiros AA; Zinner SH
    Antimicrob Agents Chemother; 1996 Mar; 40(3):734-8. PubMed ID: 8851602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibilities of Escherichia coli and Klebsiella spp. to ampicillin-sulbactam and amoxicillin-clavulanic acid.
    Kacmaz B; Sultan N
    Jpn J Infect Dis; 2007 Jul; 60(4):227-9. PubMed ID: 17642541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli resistant to ampicillin/sulbactam.
    Eng RH; Yen K; Smith SM; Citron DM; Goldstein EJ; Greenberg R; Cherubin CE
    Chemotherapy; 1992; 38(6):399-404. PubMed ID: 1288964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.
    Jones RN; Barry AL; Thornsberry C; Wilson HW
    Am J Clin Pathol; 1985 Oct; 84(4):496-504. PubMed ID: 2994461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
    Cherubin CE; Eng RH; Smith SM; Tan EN
    J Antimicrob Chemother; 1991 Jul; 28(1):61-70. PubMed ID: 1769944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical response.
    Jones RN; Dudley MN
    Diagn Microbiol Infect Dis; 1997 May; 28(1):5-18. PubMed ID: 9218913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of clinical isolates of Haemophilus influenzae to ampicillin-sulbactam.
    Mortensen JE; LaRocco M; Himes SL; Inderlied C; Daly JA; Campos JM; Mendelman PM
    Diagn Microbiol Infect Dis; 1990; 13(4):341-4. PubMed ID: 2076596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of bacterial strains producing sulbactam- or tazobactam-sensitive beta-lactamases by the use of disks containing the inhibitors alone instead of combining them with antibiotics.
    Banic S
    APMIS; 2006 Jan; 114(1):3-9. PubMed ID: 16499654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Lactam resistance phenotype determination in Escherichia coli isolates from University Malaya Medical Centre.
    Wong JS; Mohd Azri ZA; Subramaniam G; Ho SE; Palasubramaniam S; Navaratnam P
    Malays J Pathol; 2003 Dec; 25(2):113-9. PubMed ID: 16196367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.